IKZF1 and plasma cell myeloma: CC-92480 induces rapid degradation of the transcription factors IKZF1/3, leading to immune-stimulatory effects and apoptosis of myeloma cells, including those resistant to lenalidomide and pomalidomide [210,211,212,213].